Stock Research: Omnicell

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Omnicell

NSQ:OMCL US68213N1090
89
  • Value
    45
  • Growth
    63
  • Safety
    Safety
    60
  • Combined
    67
  • Sentiment
    97
  • 360° View
    360° View
    89
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The company operates in the healthcare system industry, focusing on optimizing clinical and business outcomes through robotics, smart devices, intelligent software, and services for point-of-care automation solutions like automated dispensing systems. The description does not specify different regions. In the last fiscal year, the company had a market cap of $1289 million, profits of $476 million, revenue of $1112 million, and 3670 employees.

more

ANALYSIS: With an Obermatt 360° View of 89 (better than 89% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock Omnicell are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for Omnicell. The consolidated Growth Rank has a good rank of 63, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. This means that growth is higher than for 63% of competitors in the same industry. The consolidated Safety Rank at 60 means that the company has a financing structure that is safer than 60% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a good rank of 97, which means that professional investors are more optimistic about the stock than for 97% of alternative investment opportunities. But the consolidated Value Rank is less desirable at 45, meaning that the share price of Omnicell is on the higher side compared with indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 55% of alternative stocks in the same industry. ...read more

more
Index
NASDAQ
D.J. US Medical Equipment
Robotics
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 13-Mar-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 67 76 23
Growth
63 55 3 77
Safety
Safety
60 4 86 84
Sentiment
97 10 4 79
360° View
360° View
89 4 32 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
60 22 20 60
Opinions Change
50 42 31 50
Pro Holdings
n/a 24 10 71
Market Pulse
94 31 16 50
Sentiment
97 10 4 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
45 67 76 23
Growth
63 55 3 77
Safety Safety
60 4 86 84
Combined
67 7 76 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
74 72 78 46
Price vs. Earnings (P/E)
24 59 61 40
Price vs. Book (P/B)
60 79 79 19
Dividend Yield
1 1 1 1
Value
45 67 76 23
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
31 16 1 55
Profit Growth
66 36 12 73
Capital Growth
59 63 23 25
Stock Returns
69 89 33 95
Growth
63 55 3 77
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
67 67 42 47
Refinancing
28 49 71 31
Liquidity
70 37 62 100
Safety Safety
60 4 86 84

Similar Stocks

Discover high‑ranked alternatives to Omnicell and broaden your portfolio horizons.

Zimmer

NYQ:ZBH
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Resideo Technologies

NYQ:REZI
Country: USA
Industry: Building Products
Size: Large
Full Stock Analysis

Peabody Energy

NYQ:BTU
Country: USA
Industry: Coal & Consumable Fuels
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: